Drug Profile
CL 329998
Alternative Names: DMG-MINOLatest Information Update: 13 Jan 2002
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antibacterials; Tetracyclines
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 13 Jan 2002 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)
- 06 Sep 1996 An in vitro study has been added to the antimicrobial activity section
- 20 Jun 1996 An in vitro study on the efficacy of CL 329998 against mycobacteria has been added to the antimycobacterial activity section